Journal of Cranio-Maxillo-Facial Surgery
Volume 40, Issue 2 , Pages 103-104 , February 2012

Oral cancer treatment and immune targets – A role for dendritic cells?

Received 3 December 2010 ,Accepted 1 March 2011.

References 

  1. Braun JM, Blackwell CC, Weir DM, Beuth J. Cytokine release of whole blood from adult female donors challenged with mistletoe lectin-1 standardised mistletoe extract and E. coli endotoxin or phytohaemagglutinin (PHA). Anticancer Res. 2003;23(2B):1349–1352
  2. DeNardo DG, Andreu P, Coussens LM. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 2010;29(2):309–316
  3. Elluru SR, van Huyen JP, Delignat S, Kazatchkine MD, Friboulet A, Kaveri SV, et al. Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer. BMC Cancer. 2008;8:161
  4. Hajtó T, Fodor K, Perjési P, Németh P. Difficulties and perspectives of immunomodulatory therapy with mistletoe lectins and standardized mistletoe extracts in evidence-based medicine. Evid Based Complement Alternat Med. 2009 Nov 25;Epub
  5. Heinzerling L, von Baehr V, Liebenthal C, von Baehr R, Volk HD. Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo. J Clin Immuno. 2006;26(4):347–359
  6. Horneber MA, Bueschel G, Huber R, Linde K, Rostock M. Mistletoe therapy in oncology. Cochrane Database Syst Rev. 2008;(2):CD003297
  7. Hyckel P, Metzner G, Müller P, Quade R. Prognostic relevance of histologic and immunologic parameters as a contribution to the data on individualized treatment plans for carcinoma of the mouth. Dtsch Z Mund Kiefer Gesichtschir. 1985;9(6):475–480
  8. Klopp R, Schmidt W, Werner E, Werner M, Niemer W, Beuth J. Influence of complementary Viscum album administration on microcirculation and immune system of ear, nose and throat carcinoma patients treated with radiation and chemotherapy. Anticancer Res. 2005;25(1B):601–610
  9. Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22(2):231–237
  10. Metelmann HR, Wartenberg E, Kindermann H, Platz H, Scheffler A. Direct antineoplastic activity of different mistletoe preparations against oral cancer cells in vitro. Proc AACR Clinical Investigations. 1992;33:224
  11. Swann JB, Smyth MJJ. Immune surveillance of tumors. J Clin Invest. 2007;117(5):1137–1146
  12. Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Curr Opin Genet Dev. 2008;18(1):8–11
  13. Reiman JM, Kmieciak M, Manjili MH, Knutson K. Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol. June 26 2007;17(4):275–287Epub

PII: S1010-5182(11)00052-7

doi: 10.1016/j.jcms.2011.03.009

Journal of Cranio-Maxillo-Facial Surgery
Volume 40, Issue 2 , Pages 103-104 , February 2012